---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-21-105103"
form_type: "8-K"
ticker: "HYPR"
cik: "0001833769"
company_name: "Hyperfine, Inc."
filed_at: "2021-08-13T23:59:59+00:00"
generated_at: "2026-06-29T11:49:21.935451+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# HealthCor Catalio CEO Christopher Gaulin resigns; Art Cohen appointed CEO and director

## Summary
- Christopher Gaulin resigned as CEO and director on Aug 11, 2021; not due to disagreement with the company.
- Art Cohen, co-founder of HealthCor Management, appointed CEO and director, effective immediately.
- Avi Horev resigned as director on Aug 11, 2021; not due to disagreement.
- Benjamin Snedeker appointed to the board of directors, effective immediately.

## SEC filing metadata
- accession: 0001104659-21-105103
- form_type: 8-K
- ticker: HYPR
- cik: 0001833769
- company_name: Hyperfine, Inc.
- filed_at: 2021-08-13T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1833769/000110465921105103/0001104659-21-105103-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1833769/000110465921105103/tm2125037d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-21-105103
- JSON: https://secwatch.observer/filing/0001104659-21-105103.json
- Plain text: https://secwatch.observer/filing/0001104659-21-105103.txt

## Key facts
- Executive change
  Christopher Gaulin resigned as Chief Executive Officer and director at Hyperfine, Inc..
  - Action: resigned
  - Role: Chief Executive Officer and director
  source text: On August 11, 2021, Mr. Christopher Gaulin resigned as Chief Executive Officer and a director of HealthCor Catalio Acquisition Corp., a Cayman Islands exempted company (the “Company”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1833769/000110465921105103/0001104659-21-105103-index.htm
- Executive change
  Avi Horev resigned as director at Hyperfine, Inc..
  - Action: resigned
  - Role: director
  source text: Additionally, on August 11, 2021, Mr. Avi Horev resigned as a director of the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1833769/000110465921105103/0001104659-21-105103-index.htm
- Executive change
  Art Cohen was appointed as Chief Executive Officer and director at Hyperfine, Inc..
  - Action: appointed
  - Role: Chief Executive Officer and director
  source text: On August 11, 2021, the board of directors of the Company (the “Board”) appointed Mr. Art Cohen to serve as the Chief Executive Officer of the Company and as a director, effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1833769/000110465921105103/0001104659-21-105103-index.htm
- Executive change
  Benjamin Snedeker was appointed as director at Hyperfine, Inc..
  - Action: appointed
  - Role: director
  source text: On August 11, 2021, the Board appointed Mr. Benjamin Snedeker, age 45, to serve as a director on the Board.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1833769/000110465921105103/0001104659-21-105103-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.